系统生物学技术在药源性肝损伤中应用的研究进展

吴骁, , 陆益红, , 汪玉馨, , 汤道权, 樊夏雷, *

中国药学杂志 ›› 2014, Vol. 49 ›› Issue (12) : 1009-1013.

PDF(766 KB)
PDF(766 KB)
中国药学杂志 ›› 2014, Vol. 49 ›› Issue (12) : 1009-1013. DOI: 10.11669/cpj.2014.12.001
综 述

系统生物学技术在药源性肝损伤中应用的研究进展

  • 吴骁1, 2, 陆益红1, 2, 汪玉馨2, 3, 汤道权1, 樊夏雷1, 2*
作者信息 +

Research Advances in Drug-Induced Liver Injury Based on Systems Biology Technology

  • WU Xiao1, 2, LU Yi-hong1, 2, WANG Yu-xin2, 3, TANG Dao-quan1, FAN Xia-lei1, 2*
Author information +
文章历史 +

摘要

目的 药源性肝损伤(drug-induced liver injury, DILI)的临床表现和病理变化较为复杂, 传统的临床生化指标不足以全面评价其发病机制, 笔者综述近年来基于基因组学、蛋白质组学及代谢组学等系统生物学技术在肝毒性中的研究进展, 为药源性肝损伤的预防、诊断、治疗提供依据。方法 对近几年国内外采用不同组学技术研究肝损伤相关文献进行分析综述。结果 与传统评价方法相比, 系统生物学对于发现新型肝脏毒性生物标志物及探讨其形成机制更为全面, 且准确度和灵敏度更高。结论 基于基因组学、蛋白质组学、代谢组学的系统生物学技术将为肝毒性生物标记物的发掘及肝毒性诊断提供可靠的依据, 将在药品肝毒性评价、机制研究及临床诊断等方面发挥重大的作用。

Abstract

OBJECTIVE To review the development of systems biology technology such as genomics, proteomics and metabonomics in hepatotoxicity research and may provide a reference for the prevention, diagnosis, treatment of DILI. METHODS Literatures about different omics in liver injury, which were published in recent years, were summarized and reviewed. RESULTS Compared with traditional methods, systems biology technology shows higher sensitivity and accuracy in finding the liver toxicity biomarkers and comprehensive formation mechanism. CONCLUSION Based on genomics, proteomics and metabonomics, systems biology technology will provide reliable evidences for the discovery of novel hepatotoxic markers and the diagnosis of hepatotoxicity. Therefore, systems biology technology may play a major role in hepatotoxicity assessment, hepatotoxicity mechanism research and clinical diagnosis in the future.

关键词

药源性肝损伤 / 系统生物学 / 基因组学 / 蛋白质组学 / 代谢组学

Key words

drug-induced liver injury / systems biology / genomics / proteomics / metabonomics

引用本文

导出引用
吴骁, , 陆益红, , 汪玉馨, , 汤道权, 樊夏雷, *. 系统生物学技术在药源性肝损伤中应用的研究进展[J]. 中国药学杂志, 2014, 49(12): 1009-1013 https://doi.org/10.11669/cpj.2014.12.001
WU Xiao, , LU Yi-hong, , WANG Yu-xin, , TANG Dao-quan, FAN Xia-lei, *. Research Advances in Drug-Induced Liver Injury Based on Systems Biology Technology[J]. Chinese Pharmaceutical Journal, 2014, 49(12): 1009-1013 https://doi.org/10.11669/cpj.2014.12.001
中图分类号: R969   

参考文献

[1] SHI Q, HONG H, SENIOR J, et al. Biomarkers for drug-induced liver injury. Expert Rev Gastroenter Hepatol, 2010, 4(2):225-234.[2] JAESCHKE H, MCGILL M R, RAMACHANDRAN A. Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: Lessons learned from acetaminophen hepatotoxicity. Drug Metab Rev, 2012, 44(1):88-106.[3] DROBN Z, WALTON F S, PAUL D S, et al. Metabolism of arsenic in human liver: The role of membrane transporters. Arch Toxicol , 2010, 84(1):3-16.[4] BEGRICHE K, MASSART J, ROBIN M A, et al. Drug-induced toxicity on mitochondria and lipid metabolism:Mechanistic diversity and deleterious consequences for the liver.J Hepatol, 2011, 54(4):773-794.[5] ZHANG X, LIU F, CHEN X, et al.Involvement of the immune system in idiosyncratic drug reactions.Drug Metab Pharm, 2011, 26(1):47-59.[6] YUAN L, KAPLOWITZ N. Mechanisms of drug-induced liver injury. Clin Liver Dis , 2013, 17(4):507-518.[7] TUJIOS S, FONTANA R J. Mechanisms of drug-induced liver injury: From bedside to bench. Na Rev Gastroenterol Hepatol , 2011, 8(4):202-211.[8] JU C, REILLY T. Role of immune reactions in drug-induced liver injury (DILI). Drug Metab Rev, 2012, 44(1):107-115. [9] CHALASANI N, BJRNSSON E. Risk factors for idiosyncratic drug-induced liver injury. Gastroenterology, 2010, 138(7):2246-2259. AMACHER D E. The primary role of hepatic metabolism in idiosyncratic drug-induced liver injury. Expert Opin Drug Metab Toxicol , 2012, 8(3):335-347. POVERO D, BUSLETTA C, NOVO E, et al. Liver fibrosis: A dynamic and potentially reversible process. Histol Histopathol, 2010, 25(8):1075. AGARWAL V K, MCHUTCHISON J G, HOOFNAGLE J H. Important elements for the diagnosis of drug-induced liver injury. Clini Gastroenterol Hepatol , 2010, 8(5):463-470. DEVARBHAVI H, DIERKHISING R, KREMERS W K, et al. Single-center experience with drug-induced liver injury from India: Causes, outcome, prognosis, and predictors of mortality. American J Gastroenterol , 2010, 105(11):2396-2404. BJRNSSON E. Review article: Drug-induced liver injury in clinical practice. Aliment Pharmacol Ther, 2010, 32(1):3-13. BJRNSSON E, DAVIDSDOTTIR L. The long-term follow-up after idiosyncratic drug-induced liver injury with jaundice. J Hepatol, 2009, 50(3):511-517. PAN X F, DU B, FAN Q, et al. The statistic analysis of 4 076 patients with drug induced liver injury. Mil Med J South China(华西国防医学杂志), 2009, 11(6):505-507. MENDRICK D L, SCHNACKENBERG L. Genomic and metabolomic advances in the identification of disease and adverse event biomarkers. Biomarkers Med, 2009, 3(5):605-615. VAN SUMMEREN A, RENES J, VAN DELFT J H M, et al. Proteomics in the search for mechanisms and biomarkers of drug-induced hepatotoxicity. Toxicology In Vitro, 2012, 26(3):373-385. YANG X, GREENHAW J, SHI Q, et al. Identification of urinary microRNA profiles in rats that may diagnose hepatotoxicity. Toxicolog Sci, 2012, 125(2):335-344. UEHARA T, ONO A, MARUYAMA T, et al. The Japanese toxicogenomics project: Application of toxicogenomics. Molecular Nutrition Food Res, 2010, 54(2):218-227. MULLER P Y, DIETERLE F. Tissue-specific, non-invasive toxicity biomarkers: Translation from preclinical safety assessment to clinical safety monitoring. Expert Opin Drug Metab Toxicol, 2009, 5(9):1023-1038. UEHARA T, MINOWA Y, MORIKAWA Y, et al. Prediction model of potential hepatocarcinogenicity of rat hepatocarcinogens using a large-scale toxicogenomics database. Toxicol Applied Pharmacol, 2011, 255(3):297-306. YASOKAWA D, IWAHASHI H. Toxicogenomics using yeast DNA microarrays. J Bio Sci Bioeng, 2010, 110(5):511-522. INADERA H, TACHIBANA S, SUZUKI A, et al. Carbon tetrachloride affects inflammation-related biochemical networks in the mouse liver as identified by a customized cDNA microarray system. Environ Health Preven Med, 2010, 15(2):105-114. ZHANG Y, JIANG Z, SU Y, et al. Gene expression profiling reveals potential key pathways involved in pyrazinamide-mediated hepatotoxicity in Wistar rats. J Appl Toxicol, 2013, 33(8):807-819. IWANO S, ASAOKA Y, AKIYAMA H, et al. A possible mechanism for hepatotoxicity induced by BIRB 796, an orally active p38 mitogen-activated protein kinase inhibitor. J Appl Toxicol, 2011, 31(7):671-677. HARRILL A H, ROSS P K, GATTI D M, et al. Population-based discovery of toxicogenomics biomarkers for hepatotoxicity using a laboratory strain diversity panel. Toxicol Sci, 2009, 110(1):235-243. KIYOSAWA N, UEHARA T, GAO W, et al. Identification of glutathione depletion-responsive genes using phorone-treated rat liver. J Toxicol Sci, 2007, 32(5):469-486. ABDULLAH A, KITTERINGHAM N R, JENKINS R E, et al. Analysis of the role of Nrf2 in the expression of liver proteins in mice using two-dimensional gel-based proteomics. Pharmacol Reports, 2012, 64(680):680-697. YAMADA M, SATOH M, SEIMIYA M, et al. Combined proteomic analysis of liver tissue and serum in chronically alcohol-fed rats. Alcoholism: Clinical and Experi Res, 2013, 37(s1):79-87. KHARBANDA K K, TODERO S L, KING A L, et al. Betaine treatment attenuates chronic ethanol-induced hepatic steatosis and alterations to the mitochondrial respiratory chain proteome. Inter J Hepatoly, 2012, Article ID 962183, 10 pages. ANDRINGA K K, KING A L, ECCLESTON H B, et al. Analysis of the liver mitochondrial proteome in response to ethanol and S-adenosylmethionine treatments: Novel molecular targets of disease and hepatoprotection. Am J Physiol-Gastrointest Liver Physiol, 2010, 298(5):732-745. GUAN Y, SU S. Bio-chip technology and its application development on the traditional Chinese medicine research. China J Tradit Chin Med Pharm(中国医药学报), 2012, 27(2): 422-425. GRY M, BERGSTRM J, LENGQUIST J, et al. Protein Profiling in Alanine Aminotransferase Induced Patient cohort using Acetaminophen. World Acad Sci Eng Technol, 2012, 6(64):513-515. YUN T Y, JUN X, QIAN S Y, et al. Protein microarray and ELISA method for primary liver cancer detection of tumor markers. Shandong Med J (山东医药), 2009, 49(16):55-56. ZHANG Y P.Clinical application of protein chip technique in diagnosis and estimating the efficacy of transcatheter arterial chemoembolization of hepatocellular carcinoma. Shanxi:Shanxi Medical University, 2011. CHO Y E, SINGH T S K, LEE H C, et al. In-depth identification of pathways related to cisplatin-induced hepatotoxicity through an integrative method based on an informatics-assisted label-free protein quantitation and microarray gene expression approach. Mol Cell Proteomics, 2012, 11(1). WANG Z, KANG H, JI L, et al. Proteomic characterization of the possible molecular targets of pyrrolizidine alkaloid isoline-induced hepatotoxicity. Environ Toxicol Pharmacol, 2012, 34(2):608-617. CHO Y E, KIM S H, BAEK M C. Proteome profiling of tolbutamide-treated rat primary hepatocytes using nano LC-MS/MS and label-free protein quantitation. Electrophoresis, 2012, 33(18):2806-2817. SUN J, ANDO Y, AHLBORY-DIEKER D, et al. Systems biology investigation to discover metabolic biomarkers of acetaminophen-induced hepatic injury using integrated transcriptomics and metabolomics. J Mol Biomark Diagn S, 2013, 1: 2. PARVEEN A, RIZVI S H M, GUPTA A, et al. NMR-based metabonomics study of sub-acute hepatotoxicity induced by silica nanoparticles in rats after intranasal exposure. Cell Mol Biol, 2012, 58(1):196-203. LIN B, ZHANG H, LIN Z, et al. Studies of single-walled carbon nanotubes-induced hepatotoxicity by NMR-based metabonomics of rat blood plasma and liver extracts. Nanoscale Res Letters, 2013, 8(1):1-11. BANDO K, KUNIMATSU T, SAKAI J, et al. GC-MS-based metabolomics reveals mechanism of action for hydrazine induced hepatotoxicity in rats. J Appl Toxicol , 2011, 31(6):524-535. LU X, HU B, SHAO L, et al. Integrated analysis of transcriptomics and metabonomics profiles in aflatoxin B1-induced hepatotoxicity in rat. Food Chem Toxicol, 2013, 55:444-455. LIU A, CHEN Y, YANG Z, et al. New metabolites of fenofibrate in Sprague-Dawley rats by UPLC-ESI-QTOF-MS-based metabolomics coupled with LC-MS/MS. Xenobiotica, 2009, 39(4):345-354. LU Y, SUN J, PETROVA K, et al. Metabolomics evaluation of the effects of green tea extract on acetaminophen-induced hepatotoxicity in mice. Food Chem Toxicol, 2013, 62: 707-721. SOGA T, SUGIMOTO M, HONMA M, et al. Serum metabolomics reveals γ-glutamyl dipeptides as biomarkers for discrimination among different forms of liver disease. J Hepatol, 2011, 55(4):896-905. SHIMA N, MIYAWAKI I, BANDO K, et al. Influences of methamphetamine-induced acute intoxication on urinary and plasma metabolic profiles in the rat. Toxicology, 2011, 287(1):29-37.
PDF(766 KB)

Accesses

Citation

Detail

段落导航
相关文章

/